| Company/Division name | PCI Pharma Services |
| Parent company | PCI Pharma Services |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 250 |
| Year reshoring announced: | 2023 |
| Year reshoring implemented or to be implemented: | 2024 |
| Capital investment ($): | 50 |
| Country(ies) from which reshored: | United States |
| City reshored to: | Rockford |
| State(s) reshored to: | IL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | injectable drug-delivery devices |
| What domestic positive factors made reshoring more attractive? | Eco-system synergies |
